Adaptyv Bio
PulseAugur coverage of Adaptyv Bio — every cluster mentioning Adaptyv Bio across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Anthropic and Adaptyv Bio launch AI-powered protein design competition
Anthropic and Adaptyv Bio have partnered to launch a protein design competition. The competition aims to leverage AI and automation to advance protein design capabilities. Claude, Anthropic's AI model, is expected to pl…
-
Anthropic AI models achieve breakthroughs in protein design and Venus mapping
Anthropic's AI models have demonstrated significant capabilities in scientific research and optimization. Claude Mythos 5.1 achieved a 50% success rate in designing protein binders, a substantial improvement over the ty…
-
Anthropic releases Claude Fable 5.1 with top benchmarks and lower prices · 1 source tracked
Anthropic has released Claude Fable 5.1 and Mythos 5.1, achieving top performance across eight benchmarks and reducing prices by up to 45% for certain tasks. Fable 5.1 demonstrates improved multi-step reasoning and bett…
-
AI in Drug Discovery: Algorithms vs. Full Pipeline Value
Two recent AI-driven pharmaceutical developments, one from Anthropic and another from Moderna, have generated significant public interest. Anthropic utilized its Claude model to autonomously design protein binders for 1…
-
Anthropic's Claude AI designs 14/15 disease-targeting proteins autonomously
Anthropic's Claude language models, specifically Mythos Preview and Opus 4.8, have autonomously designed proteins capable of binding to 14 out of 15 targeted diseases. These AI-generated proteins were synthesized and te…
-
Anthropic's Claude AI designs 14 protein binders, outperforming industry norms
Anthropic's Claude AI has successfully designed protein binders for 14 out of 15 targets, with two independent labs synthesizing and testing these designs. The AI achieved hit rates of 26.7% and 22.6%, significantly hig…
-
Anthropic's Claude autonomously designs proteins, exceeding industry benchmarks · 4 sources tracked
Anthropic's Claude models have demonstrated a significant capability in autonomous protein design, a crucial step in drug discovery. Research indicates that Claude, using its tools and internet access with a single expe…
-
Anthropic's Claude AI designs protein binders with high success rate · 6 sources tracked
Anthropic has released a technical report detailing how its Claude model was used to design novel protein binders, a crucial step in drug development. The AI model successfully designed binders for 14 out of 15 targets,…